Skip to main content
. 2017 Sep 1;34(10):171. doi: 10.1007/s12032-017-1034-y

Fig. 2.

Fig. 2

a Survival rates after WEHI164 inoculation in BALB/c and scid mice: WEHI164 were intraperitoneally administered to BALB/c and scid mice, and the mice were observed for 60 days. b Survival rate in splenocyte mononuclear cell (SMC)-transfused scid mice after WEHI164 cell inoculation: immunized or non-immunized SMCs were transfused. After tumor cell inoculation, the mice were observed for 30 days. c Survival rates in CD3+ cell-transfused scid mice after WEHI164 cell inoculation: immunized or non-immunized CD3+ cells were transfused. After tumor inoculation, the mice were observed for 4 weeks